{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "19884590",
  "DateCompleted": {
    "Year": "2009",
    "Month": "12",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2015",
    "Month": "11",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1001/archpediatrics.2009.186"
    ],
    "Journal": {
      "ISSN": "1538-3628",
      "JournalIssue": {
        "Volume": "163",
        "Issue": "11",
        "PubDate": {
          "Year": "2009",
          "Month": "Nov"
        }
      },
      "Title": "Archives of pediatrics & adolescent medicine",
      "ISOAbbreviation": "Arch Pediatr Adolesc Med"
    },
    "ArticleTitle": "Case-control study of a gastroschisis cluster in Nevada.",
    "Pagination": {
      "StartPage": "1000",
      "EndPage": "1006",
      "MedlinePgn": "1000-6"
    },
    "Abstract": {
      "AbstractText": [
        "To identify potential risk factors associated with a sudden increase in gastroschisis cases in northern Nevada.",
        "Case-control study.",
        "Medical centers and a pregnancy care center in Reno, Nevada.",
        "Participants (n = 14) were women who gave birth to infants with gastroschisis at either of the 2 medical centers in Reno, Nevada, from April 5, 2007, through April 4, 2008. Controls (n = 57) were selected from the same pregnancy center providing perinatal care to the cases and were matched 4:1 to the case mothers by maternal date of birth within 1 year.",
        "Environmental exposures and illnesses during pregnancy.",
        "Association of gastroschisis with illnesses, medications, or environmental exposures.",
        "Gastroschisis was associated with the use of methamphetamine (odds ratio [OR], 7.15; 95% confidence interval [CI], 1.35-37.99) or any vasoconstrictive recreational drug (methamphetamine, amphetamine, cocaine, ecstasy) (OR, 4.46; 95% CI, 1.21-16.44) before pregnancy. When we limited self-reported illnesses to those occurring during the first trimester of pregnancy, chest colds (OR, 16.77; 95% CI, 1.88-150.27) and sore throats (OR, 12.72; 95% CI, 1.32-122.52) were associated with gastroschisis.",
        "These findings add strength to the hypothesis that use of methamphetamine and related drugs is a risk factor for gastroschisis and raise questions about the risks associated with infections."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Nevada, School of Community Health Sciences, Lombardi, Reno, NV 89557, USA. lelliott@unr.edu"
          }
        ],
        "LastName": "Elliott",
        "ForeName": "Leslie",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Loomis",
        "ForeName": "Dana",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lottritz",
        "ForeName": "Lisa",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Slotnick",
        "ForeName": "Robert Nathan",
        "Initials": "RN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Oki",
        "ForeName": "Earle",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Todd",
        "ForeName": "Randall",
        "Initials": "R"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Arch Pediatr Adolesc Med",
    "NlmUniqueID": "9422751",
    "ISSNLinking": "1072-4710"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nasal Decongestants"
    },
    {
      "RegistryNumber": "7CUC9DDI9F",
      "NameOfSubstance": "Pseudoephedrine"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Arch Pediatr Adolesc Med. 2010 Jun;164(6):583; author reply 583-4",
      "PMID": "20530313"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Case-Control Studies"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "epidemiology",
        "etiology"
      ],
      "DescriptorName": "Gastroschisis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant, Newborn"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Nasal Decongestants"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Nevada"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Pharyngitis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pregnancy"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Pseudoephedrine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Substance-Related Disorders"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Surveys and Questionnaires"
    }
  ]
}